Diabetic Macular Edema

Diabetic retinopathy can cause swelling of the center of the retina, the macula, and vision loss.

What is a Diabetic Macular Edema

Diabetic macular edema is swelling in the retina associated with diabetes. This swelling can blur and distort the vision. The swelling occurs because the walls of the small blood vessels are progressively more damaged in diabetes, and there is leakage of blood and fluid into the cells of the retina. There are a variety of options to treat diabetic macular edema. The oldest treatment is laser for retinal swelling. It has been studied for decades and has been shown to be safe and effective. As with all treatments, it is not curative, and it is not without risk, but laser is one of the safest things that we do in diabetic retinal care. Other newer treatments for diabetic retinal swelling have been shown to improve vision even more than laser in some cases, and have also been shown to be safe and effective in large modern trials. These treatments are a variety of injections given into the eye in the office, and they are sometimes given alone and sometimes given with laser in addition. There are two major classes of injections used in diabetic macular edema, and those are small molecule injections and corticosteroid injections. The injections work in different ways to reduce the leakage and swelling in the retina, and sometimes the different types of injections are both used. The injections are administered under local anesthesia, and are often relatively well-tolerated by patients. Injections are also amongst the safest procedures performed in the retinal clinic, and the specific risks and benefits of injections will be discussed by your doctor. Most patients with blurred vision from diabetic macular edema enjoy an improvement in vision with treatment. Often, treatment to maintain vision is ongoing, and the long-term treatment plan is individualized to each specific patient in our practice.

What is a Laser?

When diabetic macular edema is caused by focal areas of leakage, laser treatment can be helpful. Studies were done in the 1980's validating the use of laser to reduce the risk of vision loss and improve vision in patients with diabetic macular edema. The advantage of laser of intravitreal injections is that laser treatment usually only needs to be repeated a few times. Intravireal injections are given monthly. The disadvantage of laser, is that it does not improve vision as much as intravitreal injections do when the center of the macula is swollen. Many physicians will use both laser and intravitreal injections depending on the area of the macula that is swollen and the findings on examination and testing.

Lucentis for Diabetic Macular Edema

Monthly Lucentis therapy is helpful for patients with diabetic macular edema. With laser only, about 15 percent of patients have substantial visual improvement at 2 years. With Lucentis therapy, about 40 percent of patients have a substantial improvement in visual acuity. Subsequent studies have shown that ongoing monthly treatment is usually not necessary to maintain the visual benefit.


Diabetic Macular Edema NEWS

Below are current articles from a Google News Feed on Diabetic Macular Edema

This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2017-2026
PR Newswire (press release)
The research provides insights into Diabetic Macular Edema epidemiology, Diabetic Macular Edema diagnosed patients, and Diabetic Macular Edema treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of ...

and more »

Global Diabetic Macular Edema Epidemiology and Patient Flow Analysis 2018 - ResearchAndMarkets.com
Business Wire (press release)
The research provides insights into Diabetic Macular Edema epidemiology, Diabetic Macular Edema diagnosed patients, and Diabetic Macular Edema treatment rate for US, Japan, and EU5 countries. The research measures key indicators including prevalence of ...
Range of coping strategies found in patients with vision loss from diabetesHealio

all 3 news articles »

Frequency of Bevacizumab and Ranibizumab Injections for Diabetic Macular Edema in Medicare Beneficiaries
Healio
From Warren Alpert Medical School of Brown University, Providence, RI (CMW, AMW); the Division of Ophthalmology, Alpert Medical School, Brown University, Providence, RI (PBG); Section of Ophthalmology, Providence VA Medical Center, Providence, RI (PBG ...


Endocrinology Advisor

Light Mask to Inhibit Dark Adaptation Does Not Prevent Diabetic Macular Edema Progression
Endocrinology Advisor
An organic light-emitting sleep mask did not offer long-term therapeutic benefit in patients with non-central diabetic macular edema, according to the results of the CLEOPATRA study published in The Lancet Diabetes-Endocrinology. Diabetes decreases the ...


TheHealthSite

Diabetic Macular Edema: What it is and how to prevent it
TheHealthSite
India is currently known to be the diabetes capital of the world. According to the International Diabetes Federation (IDF), nearly 6.68 crore people in India suffer from diabetes. Diabetes brings along with it tons of other ailments like Diabetic ...
Diabetic Macular Edema (DME) Market Dynamics, Segments, Size and Demand 2027Pharmaceuticals News
Drugs for Diabetic Macular Edema Market Overview, Market By Type, By Manufacturers, Regions, Industry Analysis ...Healthcare Trends

all 3 news articles »

Facts of Week

Diabetic Macular Edema (DME) Market Overview, Growth Opportunities, Market Demands, Industry Analysis & Forecast ...
Healthcare Journal
Diabetic Macular Edema (DME) market analyzes the Present and future prospects of the Diabetic Macular Edema (DME) market worldwide. Diabetic Macular Edema (DME) Market Growth, Future Prospects and Competitive Analysis, 2016–2027 offers strategic ...
Diabetic Macular Edema Treatment Market Analysis, opportunities Trends And Industry Strategies 2018 – 2026 ...Facts of Week

all 4 news articles »

Diabetic Macular Edema (DME) Epidemiology Market Growth Opportunities, Analysis and Forecasts Report 2018-2027
Healthcare Journal
Diabetic Macular Edema (DME) -Epidemiology Forecast to 2027 Market Forecast, 2027” report provides a comprehensive analysis of the Diabetic Macular Edema (DME) -Epidemiology Forecast to 2027 epidemiology, providing the historical and forecasted data ...

and more »

The Columnist

Diabetic Macular Edema Market Potential Growth, Share, Demand And Analysis Of Key Players- Research Forecasts ...
Pharmaceuticals News
Diabetic Macular Edema Market” report by offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Macular Edema Market development. The report provides detailed coverage of the ...
New Research Study on Diabetic Macular Edema Therapeutics Market 2018 to 2025BelAir Daily (press release)
Diabetic Macular Edema Market Global Overview 2018- Shire Plc, Birken AG and Scioderm IncThe Columnist
Diabetic Macular Edema (DME) Market Epidemiology, Upcoming Therapies, Impact, Market Drivers and Forecast 2027Healthcare Journal

all 4 news articles »

Diabetic Macular Edema Market Size, Trends, Analysis, Leading Players & Forecast by 2023
MilTech
Macular edema is the condition when the fluid and proteins start collecting on or under the macula of the eye thereby resulting in swelling. Due to such swelling, a person's central eye vision gets distorted. Macular edema is classified into two types ...


Diabetic Macular Edema Market Insights Covering Market Dynamics and Competitive Scenario through 2027
Pharmaceuticals News
Before the launch of Lucentis for DME treatment in 2012, the use of intravitreally injected medications was less common in North America and laser photocoagulation was the primary treatment. However, Avastin and Macugen were being used off-label for ...

and more »

Coping strategies for diabetes-related eye compilations evaluated
Diabetes.co.uk
A series of coping strategies for how people manage with diabetes-related sight problems have been evaluated as part of a new study. It is hoped understanding how people deal with diabetes-related eye complications might help develop future ...


ThromboGenics Reports Initial Data from its Clinical Study evaluating THR-317, an anti-PlGF, for the Treatment of ...
GlobeNewswire (press release)
Leuven, Belgium, April 4, 2018 - 7.30 AM CET - ThromboGenics NV (Euronext Brussels: THR), a biotechnology company developing novel medicines for back of the eye diseases and focused on diabetic eye disease, reports topline results from a Phase 1/2 ...

and more »

BetaKit

SemaThera raises $2 million to develop solution for diabetic macular edema
BetaKit
The funding was raised from Japan-based Senju Pharmaceutical and AmorChem to develop its lead candidate, ST-102, in preparation for a clinical trial application in diabetic macular edema (DME), an accumulation of fluid due to leaking blood vessels in ...


Global Diabetic Retinopathy Market Growth Analysis in Next Five Years
Medgadget (blog)
However, paucity of skilled ophthalmologist, lack of primary infrastructure and insurance facilities are some of the restraining factors that are hampering the growth of diabetic retinopathy market. The global diabetic retinopathy treatment market is ...

and more »

Diabetic Macular Edema Market 2018 Opportunities, Driving Factors by Manufacturers, Regions, Type and Application ...
Healthcare Journal
Diabetic Macular Edema Market Report Provides an in-depth exhaustive Diabetic Macular Edema market analysis and future prospects of Diabetic Macular Edema market. Diabetic Macular Edema Market report offers comprehensive Insight of the pipeline (under ...

and more »

The Lincolnian Online

IRIDEX to Report First Quarter 2018 Financial Results on May 3, 2018
GlobeNewswire (press release)
IRIDEX Corporation is a worldwide leader in developing, manufacturing, and marketing innovative and versatile laser-based medical systems, delivery devices and consumable instrumentation for the ophthalmology market. The Company's proprietary ...
IRIDEX to Report First Quarter 2018 Financial Results on May 3 ...Nasdaq

all 18 news articles »

WebMD

FDA permits marketing of artificial intelligence-based device to detect certain diabetes-related eye problems
FDA.gov
Patients who have a history of laser treatment, surgery or injections in the eye or who have any of the following conditions should not be screened for diabetic retinopathy with IDx-DR: persistent vision loss, blurred vision, floaters, previously ...
FDA OKs AI Device to Detect Diabetic RetinopathyWebMD
FDA approves sale of device that detects diabetic eye diseaseUPI.com
FDA Approves Unique Device for Diabetic Retinopathy ScreeningMonthly Prescribing Reference
Engadget -MedPage Today
all 187 news articles »

Risk factors for requirement of filtration surgery after vitrectomy in patients with proliferative diabetic retinopathy
Dove Medical Press
We collected data on the following 16 variables: sex, age, history of panretinal photocoagulation completed within 3 months before vitrectomy, presence/absence of a lens, obvious iris/angle neovascularization, tractional retinal detachment, diabetic ...

and more »

Verseon Presents Anticancer Drug Candidates Targeting Multidrug Resistant Cancers
Post-Bulletin
In addition to the oncology program, the company currently has drug programs in anticoagulation, diabetic macular edema, and hereditary angioedema. About Verseon's oncology program. Verseon plans to use its promising class of tubulin inhibitors to ...


Diabetic Macular Edema Market 2018 by Production, Capacity Utilization Rate, Revenue, Cost and Gross Margin ...
Healthcare Journal
Diabetic Macular Edema Market 2018 Report Point on in-depth Diabetic Macular Edema market analysis with future prospects of Diabetic Macular Edema market. Diabetic Macular Edema Market research report includes diverse topics like total market size, key ...

and more »

KalVista Pharmaceuticals to Present Data at The Association for Research in Vision and Ophthalmology (ARVO) 2018 ...
Watertown Public Opinion
CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2018--KalVista Pharmaceuticals, Inc. (NASDAQ: KALV), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of small molecule protease inhibitors, today announced ...


MD Magazine

TRP with Ranibizumab Fails Improve DME Visual Outcome, Treatment Burden
MD Magazine
In a recent study of 40 eyes with diabetic macular edema (DME), researchers found no evidence that adding targeted retinal photocoagulation (TRP) to ranibizumab treatment improved visual outcomes, decreased treatment burden, or reduced demand for anti ...


FDA Approves Artificial Intelligence-Based Device to Detect Certain Diabetes-Related Eye Problems
P&T Community
Patients who have a history of laser treatment, surgery, or injections in the eye or who have any of the following conditions should not be screened for diabetic retinopathy with IDx-DR: persistent vision loss, blurred vision, floaters, previously ...

and more »

Diabetic Macular Edema Market Pipeline Therapeutics 2018 Product Description, Key Companies and Table of Content
Healthcare Journal
Diabetic Macular Edema Market Pipeline Review, tracks core statistics comprising key pipeline therapeutics and drug profiles with mechanism of action (MoA), route of administration (RoA), molecule type as well as Diabetic Macular Edema Market report ...


Drugs for Diabetic Macular Edema Market Overview, Cost Structure Analysis, Growth Opportunities And Forecast To 2022
Pharmaceuticals News
The data and the information regarding the Drugs for Diabetic Macular Edema industry are taken from reliable sources such as websites, annual reports of the companies, journals, and others and were checked and validated by the market experts. Click ...

and more »

GlobeNewswire (press release)

EyePoint Pharmaceuticals Announces Third Quarter Fiscal Year 2018 Financial Results Release Date and Conference ...
GlobeNewswire (press release)
ILUVIEN® (fluocinolone acetonide intravitreal implant), a micro-insert for diabetic macular edema, licensed to Alimera Sciences, is currently sold directly in the U.S. and several EU countries. Retisert® (fluocinolone acetonide intravitreal implant ...

and more »

Global Diabetic Macular Edema (DME) Market Key Trends, Challenges and Standardization, Research, Key Players ...
Pharmaceuticals News
Diabetic Macular Edema (DME) Market report provides a Detailed analysis of the Epidemiology Forecast to 2027, providing the historical and forecasted data for the 7MM during the forecast period from 2016-2027. Diabetic Macular Edema (DME) market ...

and more »

Healthcare Journal

Vascular Endothelial Growth Factor B (VEGF Related Factor or VEGFB) – Pipeline Review, H1 2018
Healthcare Journal
Report covers products from therapy areas Metabolic Disorders, Ophthalmology and Oncology which include indications Wet (Neovascular / Exudative) Macular Degeneration, Diabetic Macular Edema, Diabetic Nephropathy, Diabetic Retinopathy, Choroidal ...


Orange County Business Journal

Allergan Opens, Closes, Window on Shire
Orange County Business Journal
Allergan PLC won't pursue a deal to buy Shire PLC, the company said, after earlier considering a bid. The drug maker said early Thursday it was eyeing a bid for Shire but shares dropped about 7% on the news and a more recent report said the company ...
Allergan Issues Statement Regarding Press Speculation on its Strategic Review - AllerganAllergan
Shire Plc - SHPG - Stock Price Today - ZacksZacks
Shire Plc Share Price - SHP, RNS News, Articles, Quotes, & Charts (LON:SHP, SHP.L) - Proactive InvestorsProactive Investors

all 226 news articles »

Trend Expected to Guide Diabetic Macular Edema Pipeline Market from 2020: Growth Analysis by Manufacturers ...
Pharmaceuticals News
Diabetic Macular Edema Pipeline Market” report by offers comprehensive Insight of the pipeline (under development) therapeutics scenario and growth prospects across Diabetic Macular Edema Pipeline Market development. The report provides detailed ...
Diabetic Macular Edema (DME) Market Global Industry Analysis, Top Company, Research Forecast, Analysis and ...Healthcare Journal

all 2 news articles »
» Load more